Skip to main content

and
  1. No Access

    Article

    Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic...

    Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari in Leukemia (2024)

  2. Article

    Open Access

    French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

    Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be ...

    Matthieu Groh, Julien Rohmer, Nicolas Etienne in Orphanet Journal of Rare Diseases (2023)

  3. No Access

    Article

    Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

    In the current classification of the World Health Organization (WHO), bone marrow mastocytosis (BMM) is a provisional variant of indolent systemic mastocytosis (ISM) defined by bone marrow involvement and abse...

    Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, Wolfgang R. Sperr in Leukemia (2022)

  4. No Access

    Article

    Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

    Systemic mastocytosis (SM) is frequently associated with eosinophilia. To examine its prevalence and clinical impact in all WHO classification-based subcategories, we analyzed eosinophil counts in 2350 mastocy...

    Hanneke C. Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, Bjorn van Anrooij in Leukemia (2020)